News
Oral Corticosteroids Deemed Ineffective for Rhinosinusitis
Systemic corticosteroids are not effective for symptom control in patients with acute rhinosinusitis.
Your search for oral corticosteroids returned 42 results
Drug News
High Risk of Pulmonary Embolism Seen in Severe Asthma
Patients with asthma are at higher risk of pulmonary embolism, particularly if the asthma is severe or they take oral corticosteroids.
ACAAI 2018
Increased Medication Burden for Patients With Both Asthma and Allergies
Patients with both asthma and allergies had a significant increase in the number of prescriptions dispensed for controller medications.
News
Do Oral Corticosteroids Reduce Symptom Duration in Acute Lower RTI?
The researchers found that the median duration of cough was 5 days in both the prednisolone and placebo groups (adjusted hazard ratio, 1.11; 95% confidence interval, 0.89 to 1.39; P=0.36).
News
Nurse-Initiated Steroids Improve Pediatric Asthma Care
Nurse initiation of oral corticosteroids before physician assessment of pediatric patients with asthma improves quality and efficiency of care provided in the pediatric emergency department.
ATS 2019
PONENTE Trial May Provide Guidance for OCS Tapering in Asthma
Benralizumab has been found to be associated with a reduction in oral corticosteroid (OCS) use while maintaining asthma control for patients with OCS-dependent severe asthma.
Case Studies
Unidentified Rash in Older Woman Baffles Multiple Clinicians
Dermatologist, allergist, primary care doctors failed to identify etiology of rash over several months
Drugs in the Pipeline
Phase 3 Study of Masitinib for the Treatment of Asthma
AB Science announced the recruitment of the first patient in its Phase 3 study evaluating masitinib for severe persistent asthma.
News
Early Treatment Key for Managing Nasal Hemangiomas
General consensus supporting early multimodality treatment for infantile hemangiomas of the nose
News
Factors Associated With Successful Biologics Tapering in RA
There were also significant differences between the groups in concomitant oral corticosteroid use (43.1 vs. 34.8% in the stable treatment and DT groups, respectively) and CRP level (1.9±2.5 vs. 1.1±1.3 respectively).
